Treatment.com Prepares AI Technology for Scale
VANCOUVER, British Columbia, Sept. 07, 2021 (GLOBE NEWSWIRE) — Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE) (OTC: TREIF), a healthcare AI technology company, has created an infrastructure designed for global scale to support better access to healthcare information for everyone. Over the past 12 weeks, Treatment has enlisted the support of developers, digital infrastructure designers and consumer research agencies to test and enhance its product and technology in preparation for launch and future growth.
“We have just completed 12 rounds of user testing running our technology through over 350 consumers and are very pleased to see the overwhelmingly positive response. Consumers are excited to use our healthcare AI to help them make better healthcare decisions and we see the potential to take this around the globe,” commented CEO, John Fraser. “We have taken the time to finesse our technology so when we decide to scale our capabilities and markets we can accomplish that in a very short time.”
With the implementation of a more scalable technology infrastructure, Treatment will be focusing more energy on the development of the go-to-market plan for their first product launch and building awareness in the investor community.
“This fall, we will turn our focus to building the launch plan for our first product and building our investor relations to ensure that we will take our place amongst the most disruptive healthcare companies in the world. We are financially sound, maintain a compressed burn rate and continue to source expert consultants to ensure we achieve success,” Fraser stated. “We welcome all our investors to keep abreast of our progress.”
Treatment.com will launch its much anticipated first product, a consumer mobile app Cara this year.
Treatment.com is a disruptive healthcare technology company that is harnessing the power of AI to help consumers improve their health through personalized recommendations and insights. Based in Vancouver and Minneapolis, the company spent the last five years working with a team of world-class doctors, engineers, mathematicians, and AI specialists to develop a complex AI engine that leverages the most robust, personalized data to generate highly predictive and accurate insights. Treatment.com is the parent company of Cara. Cara empowers consumers to take control of their health with the launch of an innovative mobile app powered by this exclusive AI engine.
For more investor information on Treatment.com please visit https://treatment.com/investors/.
Forward Looking Statement
This news release contains forward-looking statements relating to the future operations of Treatment.com, International, Inc. (Treatment) and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Treatment, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment’s expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators.
The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.
For more information:
Investor Contact: [email protected]